Parabilis Medicines, Inc. Common Stock (PBLS) — Defensive Interval Ratio

Latest as of June 2026: 195 days

Parabilis Medicines, Inc. Common Stock (PBLS) has a Defensive Interval Ratio of 195 days as of June 2026. Defensive assets of $33.64 Million (cash $-, short-term investments $33.64 Million, receivables $-) cover 195 days of daily cash needs of $172.16K/day. See working capital to net assets of Parabilis Medicines, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

195 days
Days of operational coverage

Defensive Assets

$33.64 Million
Cash + ST Investments + Receivables

Daily Cash Need

$172.16K
Current Liabilities ÷ 365

Current Liabilities

$62.84 Million
USD

Parabilis Medicines, Inc. Common Stock Defensive Interval Ratio (2024–2025)

This chart shows how Parabilis Medicines, Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the ratio stands at 195 days, meaning defensive assets of $33.64 Million can fund 195 days of operations without new revenue. Read total liabilities of Parabilis Medicines, Inc. Common Stock for a breakdown of total debt and financial obligations.

Annual Defensive Interval Ratio for Parabilis Medicines, Inc. Common Stock (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Parabilis Medicines, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Parabilis Medicines, Inc. Common Stock total assets.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 0 days $0.00 $155.59K/day $- $0.00 ▼ -462 days
2024 462 days $41.05 Million $88.80K/day $- $40.69 Million —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)